SEC Form 4 research
ACTUATE THERAPEUTICS, INC. insider transactions
| Issuer | ACTUATE THERAPEUTICS, INC. |
|---|
| Tickers | ACTU |
|---|
| Reporting owners | 37 |
|---|
| Officers and directors | 6 |
|---|
| Last public filing | 2026-10-23 |
|---|
Recent insider disclosures
No matching recent records; this is not a statement about historical activity.
Officers and directors in the directory
- Bios 2024 Co-Invest, LP — 1 qualifying
- BIOS Actuate Co-Invest I, LP — 6 qualifying
- BIOS Actuate Co-Invest II, LP — 6 qualifying
- Bios Actuate Co-Invest III, LP — 6 qualifying
- BIOS Advisors GP, LLC — 95 qualifying
- BIOS Capital Management, LP — 95 qualifying
- Bios Clinical Opportunity Fund, LP — 6 qualifying
- Bios Equity COF, LP — 6 qualifying
- Bios Equity Partners II, LP — 107 qualifying
- BIOS Equity Partners III, LP — 51 qualifying
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.